Is Pharmosa Biopharm Inc stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Pharmosa Biopharm Inc 10 years ago, but if you had invested on Tuesday 22nd of February 2022 when the price was TWD47.02, you would have made a profit of TWD10.58 per share or 22.50%
Yes, the average daily trading liquidity for Pharmosa Biopharm Inc is TWD266 783 thousand. You should therefore be able to get in and out of your positions relatively fast.
Pharmosa Biopharm Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Pharmosa Biopharm Inc to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.